Litcius/Paper detail

Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M <sup>pro</sup> ) of SARS-CoV-2 and inhibit its activity

Vipul Kumar, Jaspreet Kaur Dhanjal, Sunil C. Kaul, Renu Wadhwa, Durai Sundar

2020Journal of Biomolecular Structure and Dynamics151 citationsDOIOpen Access PDF

Abstract

with efficacy and binding energies equivalent to an already claimed N3 protease inhibitor. Similar to N3 inhibitor, Wi-N and CAPE were interacting with the highly conserved residues of the proteases of coronaviruses. The binding stability of these molecules was further analyzed using molecular dynamics simulations. The binding free energies calculated using MM/GBSA for N3 inhibitor, CAPE and Wi-N were also comparable. Data presented here predicted that these natural compounds may possess the potential to inhibit the functional activity of SARS-CoV-2 protease (an essential protein for virus survival), and hence (i) may connect to save time and cost required for designing/development, and initial screening for anti-COVID drugs, (ii) may offer some therapeutic value for the management of novel fatal coronavirus disease, (iii) warrants prioritized further validation in the laboratory and clinical tests.Communicated by Ramaswamy H. Sarma.

Topics & Concepts

Caffeic acid phenethyl esterProteaseCaffeic acidSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ChemistryCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakProtease inhibitor (pharmacology)BiochemistryVirologyEnzymeBiologyVirusMedicineAntioxidantViral loadDiseasePathologyAntiretroviral therapyOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchPhytochemicals and Medicinal PlantsComputational Drug Discovery Methods